nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ALB—acquired immunodeficiency syndrome	0.185	1	CbGaD
Nortriptyline—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0345	0.0595	CbGbCtD
Nortriptyline—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.017	0.0294	CbGbCtD
Nortriptyline—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0154	0.0266	CbGbCtD
Nortriptyline—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0154	0.0266	CbGbCtD
Nortriptyline—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.015	0.0259	CbGbCtD
Nortriptyline—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0146	0.0252	CbGbCtD
Nortriptyline—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0145	0.0251	CbGbCtD
Nortriptyline—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0139	0.024	CbGbCtD
Nortriptyline—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0137	0.0237	CbGbCtD
Nortriptyline—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0135	0.0233	CbGbCtD
Nortriptyline—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0133	0.0229	CbGbCtD
Nortriptyline—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0129	0.0223	CbGbCtD
Nortriptyline—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0127	0.0219	CbGbCtD
Nortriptyline—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0127	0.0219	CbGbCtD
Nortriptyline—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0124	0.0214	CbGbCtD
Nortriptyline—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0124	0.0214	CbGbCtD
Nortriptyline—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0121	0.021	CbGbCtD
Nortriptyline—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0201	CbGbCtD
Nortriptyline—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0201	CbGbCtD
Nortriptyline—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0115	0.0198	CbGbCtD
Nortriptyline—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0114	0.0197	CbGbCtD
Nortriptyline—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0114	0.0197	CbGbCtD
Nortriptyline—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0111	0.0192	CbGbCtD
Nortriptyline—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0107	0.0185	CbGbCtD
Nortriptyline—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0104	0.018	CbGbCtD
Nortriptyline—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0104	0.018	CbGbCtD
Nortriptyline—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0104	0.018	CbGbCtD
Nortriptyline—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0103	0.0178	CbGbCtD
Nortriptyline—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0103	0.0178	CbGbCtD
Nortriptyline—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0096	0.0166	CbGbCtD
Nortriptyline—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00944	0.0163	CbGbCtD
Nortriptyline—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00944	0.0163	CbGbCtD
Nortriptyline—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00941	0.0162	CbGbCtD
Nortriptyline—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00941	0.0162	CbGbCtD
Nortriptyline—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00902	0.0156	CbGbCtD
Nortriptyline—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00891	0.0154	CbGbCtD
Nortriptyline—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00868	0.015	CbGbCtD
Nortriptyline—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00865	0.0149	CbGbCtD
Nortriptyline—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00815	0.0141	CbGbCtD
Nortriptyline—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00791	0.0137	CbGbCtD
Nortriptyline—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00782	0.0135	CbGbCtD
Nortriptyline—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00782	0.0135	CbGbCtD
Nortriptyline—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0075	0.0129	CbGbCtD
Nortriptyline—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00715	0.0123	CbGbCtD
Nortriptyline—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00715	0.0123	CbGbCtD
Nortriptyline—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00706	0.0122	CbGbCtD
Nortriptyline—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00663	0.0115	CbGbCtD
Nortriptyline—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00663	0.0115	CbGbCtD
Nortriptyline—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.006	0.0104	CbGbCtD
Nortriptyline—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.006	0.0104	CbGbCtD
Nortriptyline—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00518	0.00894	CbGbCtD
Nortriptyline—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00503	0.00868	CbGbCtD
Nortriptyline—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00455	0.00785	CbGbCtD
Nortriptyline—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00455	0.00785	CbGbCtD
Nortriptyline—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00436	0.00753	CbGbCtD
Nortriptyline—ORM1—saliva—acquired immunodeficiency syndrome	0.00274	0.0572	CbGeAlD
Nortriptyline—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00118	0.0247	CbGeAlD
Nortriptyline—DRD2—nerve—acquired immunodeficiency syndrome	0.00108	0.0225	CbGeAlD
Nortriptyline—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00102	0.0212	CbGeAlD
Nortriptyline—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.000902	0.0188	CbGeAlD
Nortriptyline—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000842	0.0176	CbGeAlD
Nortriptyline—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000779	0.0163	CbGeAlD
Nortriptyline—HTR2A—nerve—acquired immunodeficiency syndrome	0.000711	0.0148	CbGeAlD
Nortriptyline—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000688	0.0144	CbGeAlD
Nortriptyline—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000671	0.014	CbGeAlD
Nortriptyline—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000663	0.0138	CbGeAlD
Nortriptyline—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000653	0.0136	CbGeAlD
Nortriptyline—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000619	0.0129	CbGeAlD
Nortriptyline—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000616	0.0129	CbGeAlD
Nortriptyline—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000605	0.0126	CbGeAlD
Nortriptyline—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000596	0.0124	CbGeAlD
Nortriptyline—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000593	0.0124	CbGeAlD
Nortriptyline—HTR6—nervous system—acquired immunodeficiency syndrome	0.000552	0.0115	CbGeAlD
Nortriptyline—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000538	0.0112	CbGeAlD
Nortriptyline—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000531	0.0111	CbGeAlD
Nortriptyline—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000498	0.0104	CbGeAlD
Nortriptyline—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00049	0.0102	CbGeAlD
Nortriptyline—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000482	0.0101	CbGeAlD
Nortriptyline—CHRM4—brain—acquired immunodeficiency syndrome	0.000471	0.00983	CbGeAlD
Nortriptyline—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000464	0.00968	CbGeAlD
Nortriptyline—DRD2—retina—acquired immunodeficiency syndrome	0.000446	0.00932	CbGeAlD
Nortriptyline—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00044	0.00919	CbGeAlD
Nortriptyline—ORM1—blood—acquired immunodeficiency syndrome	0.000437	0.00912	CbGeAlD
Nortriptyline—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000431	0.00899	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000424	0.00885	CbGeAlD
Nortriptyline—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000423	0.00882	CbGeAlD
Nortriptyline—HTR6—brain—acquired immunodeficiency syndrome	0.000422	0.0088	CbGeAlD
Nortriptyline—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000421	0.00878	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000415	0.00865	CbGeAlD
Nortriptyline—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000391	0.00815	CbGeAlD
Nortriptyline—ORM1—lung—acquired immunodeficiency syndrome	0.000383	0.00799	CbGeAlD
Nortriptyline—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000378	0.0079	CbGeAlD
Nortriptyline—SLC6A4—blood—acquired immunodeficiency syndrome	0.000372	0.00777	CbGeAlD
Nortriptyline—CHRM5—brain—acquired immunodeficiency syndrome	0.000368	0.00769	CbGeAlD
Nortriptyline—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000359	0.00748	CbGeAlD
Nortriptyline—ORM1—nervous system—acquired immunodeficiency syndrome	0.000355	0.0074	CbGeAlD
Nortriptyline—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000348	0.00727	CbGeAlD
Nortriptyline—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000341	0.00713	CbGeAlD
Nortriptyline—ADRA1B—brain—acquired immunodeficiency syndrome	0.000336	0.00702	CbGeAlD
Nortriptyline—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000331	0.0069	CbGeAlD
Nortriptyline—ADRA1D—brain—acquired immunodeficiency syndrome	0.000329	0.00687	CbGeAlD
Nortriptyline—SLC6A4—lung—acquired immunodeficiency syndrome	0.000326	0.00681	CbGeAlD
Nortriptyline—CHRM1—lung—acquired immunodeficiency syndrome	0.000325	0.00678	CbGeAlD
Nortriptyline—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000324	0.00676	CbGeAlD
Nortriptyline—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000324	0.00676	CbGeAlD
Nortriptyline—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000319	0.00665	CbGeAlD
Nortriptyline—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000318	0.00665	CbGeAlD
Nortriptyline—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000318	0.00664	CbGeAlD
Nortriptyline—CYP2C19—blood—acquired immunodeficiency syndrome	0.000308	0.00644	CbGeAlD
Nortriptyline—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000307	0.0064	CbGeAlD
Nortriptyline—ADRA1A—blood—acquired immunodeficiency syndrome	0.000305	0.00636	CbGeAlD
Nortriptyline—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000302	0.00631	CbGeAlD
Nortriptyline—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000301	0.00628	CbGeAlD
Nortriptyline—HTR2A—retina—acquired immunodeficiency syndrome	0.000294	0.00614	CbGeAlD
Nortriptyline—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000291	0.00607	CbGeAlD
Nortriptyline—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00029	0.00605	CbGeAlD
Nortriptyline—SLC6A2—lung—acquired immunodeficiency syndrome	0.000287	0.006	CbGeAlD
Nortriptyline—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000286	0.00598	CbGeAlD
Nortriptyline—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000286	0.00597	CbGeAlD
Nortriptyline—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000269	0.00562	CbGeAlD
Nortriptyline—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000268	0.0056	CbGeAlD
Nortriptyline—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000266	0.00555	CbGeAlD
Nortriptyline—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000264	0.00552	CbGeAlD
Nortriptyline—ORM1—lymph node—acquired immunodeficiency syndrome	0.000262	0.00547	CbGeAlD
Nortriptyline—DRD2—lung—acquired immunodeficiency syndrome	0.000262	0.00546	CbGeAlD
Nortriptyline—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000259	0.00541	CbGeAlD
Nortriptyline—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000258	0.00539	CbGeAlD
Nortriptyline—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000256	0.00535	CbGeAlD
Nortriptyline—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000255	0.00532	CbGeAlD
Nortriptyline—CHRM2—brain—acquired immunodeficiency syndrome	0.000253	0.00528	CbGeAlD
Nortriptyline—CYP1A2—blood—acquired immunodeficiency syndrome	0.000252	0.00526	CbGeAlD
Nortriptyline—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000251	0.00524	CbGeAlD
Nortriptyline—HRH1—digestive system—acquired immunodeficiency syndrome	0.000248	0.00517	CbGeAlD
Nortriptyline—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000247	0.00516	CbGeAlD
Nortriptyline—HTR2C—brain—acquired immunodeficiency syndrome	0.000244	0.00508	CbGeAlD
Nortriptyline—CYP3A5—blood—acquired immunodeficiency syndrome	0.000243	0.00507	CbGeAlD
Nortriptyline—DRD2—nervous system—acquired immunodeficiency syndrome	0.000242	0.00506	CbGeAlD
Nortriptyline—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000241	0.00503	CbGeAlD
Nortriptyline—CYP2C9—blood—acquired immunodeficiency syndrome	0.000239	0.00499	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000238	0.00497	CbGeAlD
Nortriptyline—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000238	0.00496	CbGeAlD
Nortriptyline—ALB—brain—acquired immunodeficiency syndrome	0.000238	0.00496	CbGeAlD
Nortriptyline—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000233	0.00487	CbGeAlD
Nortriptyline—SLC6A4—brain—acquired immunodeficiency syndrome	0.000231	0.00482	CbGeAlD
Nortriptyline—CHRM1—brain—acquired immunodeficiency syndrome	0.00023	0.0048	CbGeAlD
Nortriptyline—ALB—lymph node—acquired immunodeficiency syndrome	0.00023	0.00479	CbGeAlD
Nortriptyline—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000229	0.00478	CbGeAlD
Nortriptyline—CYP2E1—blood—acquired immunodeficiency syndrome	0.000227	0.00473	CbGeAlD
Nortriptyline—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000225	0.0047	CbGeAlD
Nortriptyline—CYP1A2—lung—acquired immunodeficiency syndrome	0.000221	0.00461	CbGeAlD
Nortriptyline—HRH1—vagina—acquired immunodeficiency syndrome	0.000219	0.00456	CbGeAlD
Nortriptyline—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000218	0.00456	CbGeAlD
Nortriptyline—PTGS1—blood—acquired immunodeficiency syndrome	0.000218	0.00456	CbGeAlD
Nortriptyline—CYP3A5—lung—acquired immunodeficiency syndrome	0.000213	0.00445	CbGeAlD
Nortriptyline—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.00021	0.00439	CbGeAlD
Nortriptyline—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000207	0.00431	CbGeAlD
Nortriptyline—HRH1—lung—acquired immunodeficiency syndrome	0.000207	0.00431	CbGeAlD
Nortriptyline—CHRM3—brain—acquired immunodeficiency syndrome	0.000206	0.0043	CbGeAlD
Nortriptyline—HTR1A—brain—acquired immunodeficiency syndrome	0.000205	0.00428	CbGeAlD
Nortriptyline—SLC6A2—brain—acquired immunodeficiency syndrome	0.000203	0.00424	CbGeAlD
Nortriptyline—PTGS1—vagina—acquired immunodeficiency syndrome	0.000202	0.00422	CbGeAlD
Nortriptyline—CYP2E1—lung—acquired immunodeficiency syndrome	0.000199	0.00415	CbGeAlD
Nortriptyline—HTR2A—blood—acquired immunodeficiency syndrome	0.000197	0.00411	CbGeAlD
Nortriptyline—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000196	0.0041	CbGeAlD
Nortriptyline—HRH1—nervous system—acquired immunodeficiency syndrome	0.000191	0.004	CbGeAlD
Nortriptyline—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000191	0.00399	CbGeAlD
Nortriptyline—PTGS1—lung—acquired immunodeficiency syndrome	0.000191	0.00399	CbGeAlD
Nortriptyline—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00019	0.00396	CbGeAlD
Nortriptyline—ADRA1A—brain—acquired immunodeficiency syndrome	0.000189	0.00395	CbGeAlD
Nortriptyline—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000188	0.00393	CbGeAlD
Nortriptyline—DRD2—brain—acquired immunodeficiency syndrome	0.000185	0.00387	CbGeAlD
Nortriptyline—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000184	0.00385	CbGeAlD
Nortriptyline—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000184	0.00384	CbGeAlD
Nortriptyline—HTR2A—vagina—acquired immunodeficiency syndrome	0.000183	0.00381	CbGeAlD
Nortriptyline—CYP3A4—blood—acquired immunodeficiency syndrome	0.000182	0.00381	CbGeAlD
Nortriptyline—CYP2D6—blood—acquired immunodeficiency syndrome	0.000179	0.00374	CbGeAlD
Nortriptyline—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000177	0.0037	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000177	0.0037	CbGeAlD
Nortriptyline—HTR2A—lung—acquired immunodeficiency syndrome	0.000173	0.0036	CbGeAlD
Nortriptyline—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000171	0.00356	CbGeAlD
Nortriptyline—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00016	0.00334	CbGeAlD
Nortriptyline—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000989	CcSEcCtD
Nortriptyline—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.000988	CcSEcCtD
Nortriptyline—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.000988	CcSEcCtD
Nortriptyline—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000987	CcSEcCtD
Nortriptyline—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000157	0.000985	CcSEcCtD
Nortriptyline—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000157	0.000985	CcSEcCtD
Nortriptyline—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000984	CcSEcCtD
Nortriptyline—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000982	CcSEcCtD
Nortriptyline—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.00098	CcSEcCtD
Nortriptyline—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000156	0.00098	CcSEcCtD
Nortriptyline—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000979	CcSEcCtD
Nortriptyline—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000979	CcSEcCtD
Nortriptyline—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000977	CcSEcCtD
Nortriptyline—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000155	0.000977	CcSEcCtD
Nortriptyline—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000155	0.000971	CcSEcCtD
Nortriptyline—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000155	0.000971	CcSEcCtD
Nortriptyline—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000971	CcSEcCtD
Nortriptyline—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.00097	CcSEcCtD
Nortriptyline—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000969	CcSEcCtD
Nortriptyline—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000969	CcSEcCtD
Nortriptyline—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000154	0.00321	CbGeAlD
Nortriptyline—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.000965	CcSEcCtD
Nortriptyline—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000965	CcSEcCtD
Nortriptyline—Rash—Didanosine—acquired immunodeficiency syndrome	0.000153	0.000963	CcSEcCtD
Nortriptyline—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000153	0.000962	CcSEcCtD
Nortriptyline—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000153	0.000962	CcSEcCtD
Nortriptyline—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000153	0.000962	CcSEcCtD
Nortriptyline—Headache—Didanosine—acquired immunodeficiency syndrome	0.000152	0.000956	CcSEcCtD
Nortriptyline—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000152	0.000954	CcSEcCtD
Nortriptyline—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000953	CcSEcCtD
Nortriptyline—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000953	CcSEcCtD
Nortriptyline—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000952	CcSEcCtD
Nortriptyline—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000151	0.000951	CcSEcCtD
Nortriptyline—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000951	CcSEcCtD
Nortriptyline—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000949	CcSEcCtD
Nortriptyline—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000948	CcSEcCtD
Nortriptyline—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000947	CcSEcCtD
Nortriptyline—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000947	CcSEcCtD
Nortriptyline—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000945	CcSEcCtD
Nortriptyline—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000945	CcSEcCtD
Nortriptyline—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000944	CcSEcCtD
Nortriptyline—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000943	CcSEcCtD
Nortriptyline—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00015	0.000941	CcSEcCtD
Nortriptyline—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00015	0.000939	CcSEcCtD
Nortriptyline—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000149	0.000938	CcSEcCtD
Nortriptyline—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000149	0.000937	CcSEcCtD
Nortriptyline—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000936	CcSEcCtD
Nortriptyline—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000935	CcSEcCtD
Nortriptyline—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000931	CcSEcCtD
Nortriptyline—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000931	CcSEcCtD
Nortriptyline—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000148	0.00309	CbGeAlD
Nortriptyline—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000928	CcSEcCtD
Nortriptyline—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000147	0.000924	CcSEcCtD
Nortriptyline—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000924	CcSEcCtD
Nortriptyline—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000923	CcSEcCtD
Nortriptyline—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000923	CcSEcCtD
Nortriptyline—HRH1—brain—acquired immunodeficiency syndrome	0.000146	0.00305	CbGeAlD
Nortriptyline—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000916	CcSEcCtD
Nortriptyline—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000916	CcSEcCtD
Nortriptyline—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000915	CcSEcCtD
Nortriptyline—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000915	CcSEcCtD
Nortriptyline—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000146	0.00304	CbGeAlD
Nortriptyline—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000914	CcSEcCtD
Nortriptyline—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000912	CcSEcCtD
Nortriptyline—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000911	CcSEcCtD
Nortriptyline—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000911	CcSEcCtD
Nortriptyline—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.00091	CcSEcCtD
Nortriptyline—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000909	CcSEcCtD
Nortriptyline—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000909	CcSEcCtD
Nortriptyline—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000144	0.000907	CcSEcCtD
Nortriptyline—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000144	0.000907	CcSEcCtD
Nortriptyline—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000905	CcSEcCtD
Nortriptyline—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000904	CcSEcCtD
Nortriptyline—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000903	CcSEcCtD
Nortriptyline—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000902	CcSEcCtD
Nortriptyline—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.0009	CcSEcCtD
Nortriptyline—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000896	CcSEcCtD
Nortriptyline—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000896	CcSEcCtD
Nortriptyline—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000142	0.00297	CbGeAlD
Nortriptyline—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000142	0.000893	CcSEcCtD
Nortriptyline—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000891	CcSEcCtD
Nortriptyline—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000888	CcSEcCtD
Nortriptyline—HRH1—lymph node—acquired immunodeficiency syndrome	0.000141	0.00295	CbGeAlD
Nortriptyline—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000886	CcSEcCtD
Nortriptyline—CYP2E1—brain—acquired immunodeficiency syndrome	0.000141	0.00293	CbGeAlD
Nortriptyline—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000883	CcSEcCtD
Nortriptyline—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000881	CcSEcCtD
Nortriptyline—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.00014	0.00293	CbGeAlD
Nortriptyline—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.00088	CcSEcCtD
Nortriptyline—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000879	CcSEcCtD
Nortriptyline—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00014	0.000879	CcSEcCtD
Nortriptyline—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000877	CcSEcCtD
Nortriptyline—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00014	0.000876	CcSEcCtD
Nortriptyline—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000876	CcSEcCtD
Nortriptyline—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000874	CcSEcCtD
Nortriptyline—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000873	CcSEcCtD
Nortriptyline—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000139	0.000873	CcSEcCtD
Nortriptyline—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000873	CcSEcCtD
Nortriptyline—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.00087	CcSEcCtD
Nortriptyline—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000869	CcSEcCtD
Nortriptyline—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000866	CcSEcCtD
Nortriptyline—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000866	CcSEcCtD
Nortriptyline—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000138	0.000866	CcSEcCtD
Nortriptyline—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000138	0.000865	CcSEcCtD
Nortriptyline—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000137	0.000863	CcSEcCtD
Nortriptyline—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000862	CcSEcCtD
Nortriptyline—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000861	CcSEcCtD
Nortriptyline—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000137	0.00086	CcSEcCtD
Nortriptyline—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000855	CcSEcCtD
Nortriptyline—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000854	CcSEcCtD
Nortriptyline—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000853	CcSEcCtD
Nortriptyline—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000851	CcSEcCtD
Nortriptyline—PTGS1—brain—acquired immunodeficiency syndrome	0.000135	0.00283	CbGeAlD
Nortriptyline—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000848	CcSEcCtD
Nortriptyline—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000848	CcSEcCtD
Nortriptyline—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000847	CcSEcCtD
Nortriptyline—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000847	CcSEcCtD
Nortriptyline—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.000845	CcSEcCtD
Nortriptyline—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000844	CcSEcCtD
Nortriptyline—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000134	0.000843	CcSEcCtD
Nortriptyline—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000842	CcSEcCtD
Nortriptyline—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000839	CcSEcCtD
Nortriptyline—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.000838	CcSEcCtD
Nortriptyline—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.000838	CcSEcCtD
Nortriptyline—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000837	CcSEcCtD
Nortriptyline—Rash—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000836	CcSEcCtD
Nortriptyline—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000835	CcSEcCtD
Nortriptyline—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000835	CcSEcCtD
Nortriptyline—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000834	CcSEcCtD
Nortriptyline—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000833	CcSEcCtD
Nortriptyline—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.000833	CcSEcCtD
Nortriptyline—Headache—Stavudine—acquired immunodeficiency syndrome	0.000132	0.00083	CcSEcCtD
Nortriptyline—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000132	0.00083	CcSEcCtD
Nortriptyline—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000829	CcSEcCtD
Nortriptyline—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000828	CcSEcCtD
Nortriptyline—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000132	0.000827	CcSEcCtD
Nortriptyline—Rash—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000823	CcSEcCtD
Nortriptyline—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000823	CcSEcCtD
Nortriptyline—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000822	CcSEcCtD
Nortriptyline—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000131	0.00273	CbGeAlD
Nortriptyline—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000822	CcSEcCtD
Nortriptyline—Headache—Abacavir—acquired immunodeficiency syndrome	0.00013	0.000818	CcSEcCtD
Nortriptyline—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00013	0.000815	CcSEcCtD
Nortriptyline—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.000815	CcSEcCtD
Nortriptyline—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.00081	CcSEcCtD
Nortriptyline—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000809	CcSEcCtD
Nortriptyline—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000806	CcSEcCtD
Nortriptyline—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000805	CcSEcCtD
Nortriptyline—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000804	CcSEcCtD
Nortriptyline—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000804	CcSEcCtD
Nortriptyline—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.0008	CcSEcCtD
Nortriptyline—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.0008	CcSEcCtD
Nortriptyline—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000798	CcSEcCtD
Nortriptyline—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000796	CcSEcCtD
Nortriptyline—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000795	CcSEcCtD
Nortriptyline—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000126	0.00079	CcSEcCtD
Nortriptyline—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000789	CcSEcCtD
Nortriptyline—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000788	CcSEcCtD
Nortriptyline—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000125	0.000788	CcSEcCtD
Nortriptyline—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000125	0.000787	CcSEcCtD
Nortriptyline—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000784	CcSEcCtD
Nortriptyline—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.00078	CcSEcCtD
Nortriptyline—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000779	CcSEcCtD
Nortriptyline—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000123	0.000776	CcSEcCtD
Nortriptyline—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000774	CcSEcCtD
Nortriptyline—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000772	CcSEcCtD
Nortriptyline—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000769	CcSEcCtD
Nortriptyline—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000769	CcSEcCtD
Nortriptyline—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000768	CcSEcCtD
Nortriptyline—HTR2A—brain—acquired immunodeficiency syndrome	0.000122	0.00255	CbGeAlD
Nortriptyline—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000766	CcSEcCtD
Nortriptyline—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000766	CcSEcCtD
Nortriptyline—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000766	CcSEcCtD
Nortriptyline—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000766	CcSEcCtD
Nortriptyline—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.000762	CcSEcCtD
Nortriptyline—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000759	CcSEcCtD
Nortriptyline—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000758	CcSEcCtD
Nortriptyline—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000749	CcSEcCtD
Nortriptyline—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000746	CcSEcCtD
Nortriptyline—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000744	CcSEcCtD
Nortriptyline—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000743	CcSEcCtD
Nortriptyline—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000738	CcSEcCtD
Nortriptyline—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000738	CcSEcCtD
Nortriptyline—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000737	CcSEcCtD
Nortriptyline—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000733	CcSEcCtD
Nortriptyline—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.000732	CcSEcCtD
Nortriptyline—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000731	CcSEcCtD
Nortriptyline—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000726	CcSEcCtD
Nortriptyline—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000726	CcSEcCtD
Nortriptyline—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000726	CcSEcCtD
Nortriptyline—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000724	CcSEcCtD
Nortriptyline—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000722	CcSEcCtD
Nortriptyline—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000716	CcSEcCtD
Nortriptyline—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000715	CcSEcCtD
Nortriptyline—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000714	CcSEcCtD
Nortriptyline—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000712	CcSEcCtD
Nortriptyline—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.00071	CcSEcCtD
Nortriptyline—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000709	CcSEcCtD
Nortriptyline—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000708	CcSEcCtD
Nortriptyline—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000708	CcSEcCtD
Nortriptyline—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000708	CcSEcCtD
Nortriptyline—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000703	CcSEcCtD
Nortriptyline—CYP2D6—brain—acquired immunodeficiency syndrome	0.000111	0.00232	CbGeAlD
Nortriptyline—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000695	CcSEcCtD
Nortriptyline—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000693	CcSEcCtD
Nortriptyline—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000685	CcSEcCtD
Nortriptyline—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000685	CcSEcCtD
Nortriptyline—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000684	CcSEcCtD
Nortriptyline—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000681	CcSEcCtD
Nortriptyline—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000681	CcSEcCtD
Nortriptyline—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000681	CcSEcCtD
Nortriptyline—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000678	CcSEcCtD
Nortriptyline—Rash—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000676	CcSEcCtD
Nortriptyline—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000675	CcSEcCtD
Nortriptyline—Headache—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000671	CcSEcCtD
Nortriptyline—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000669	CcSEcCtD
Nortriptyline—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000663	CcSEcCtD
Nortriptyline—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00066	CcSEcCtD
Nortriptyline—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000653	CcSEcCtD
Nortriptyline—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.00065	CcSEcCtD
Nortriptyline—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.00065	CcSEcCtD
Nortriptyline—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000644	CcSEcCtD
Nortriptyline—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000643	CcSEcCtD
Nortriptyline—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00064	CcSEcCtD
Nortriptyline—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000638	CcSEcCtD
Nortriptyline—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000638	CcSEcCtD
Nortriptyline—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000636	CcSEcCtD
Nortriptyline—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000635	CcSEcCtD
Nortriptyline—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000634	CcSEcCtD
Nortriptyline—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000634	CcSEcCtD
Nortriptyline—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000619	CcSEcCtD
Nortriptyline—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.8e-05	0.000616	CcSEcCtD
Nortriptyline—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.76e-05	0.000613	CcSEcCtD
Nortriptyline—Rash—Delavirdine—acquired immunodeficiency syndrome	9.72e-05	0.000611	CcSEcCtD
Nortriptyline—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.71e-05	0.00061	CcSEcCtD
Nortriptyline—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.00061	CcSEcCtD
Nortriptyline—Headache—Delavirdine—acquired immunodeficiency syndrome	9.66e-05	0.000607	CcSEcCtD
Nortriptyline—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.65e-05	0.000606	CcSEcCtD
Nortriptyline—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.57e-05	0.000601	CcSEcCtD
Nortriptyline—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.43e-05	0.000592	CcSEcCtD
Nortriptyline—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.39e-05	0.00059	CcSEcCtD
Nortriptyline—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.39e-05	0.00059	CcSEcCtD
Nortriptyline—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.26e-05	0.000582	CcSEcCtD
Nortriptyline—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.16e-05	0.000575	CcSEcCtD
Nortriptyline—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.08e-05	0.00057	CcSEcCtD
Nortriptyline—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.07e-05	0.000569	CcSEcCtD
Nortriptyline—Rash—Ritonavir—acquired immunodeficiency syndrome	8.99e-05	0.000565	CcSEcCtD
Nortriptyline—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.98e-05	0.000564	CcSEcCtD
Nortriptyline—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.96e-05	0.000563	CcSEcCtD
Nortriptyline—Headache—Ritonavir—acquired immunodeficiency syndrome	8.93e-05	0.000561	CcSEcCtD
Nortriptyline—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.73e-05	0.000548	CcSEcCtD
Nortriptyline—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.66e-05	0.000544	CcSEcCtD
Nortriptyline—Rash—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000544	CcSEcCtD
Nortriptyline—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.64e-05	0.000543	CcSEcCtD
Nortriptyline—Headache—Saquinavir—acquired immunodeficiency syndrome	8.6e-05	0.00054	CcSEcCtD
Nortriptyline—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.47e-05	0.000532	CcSEcCtD
Nortriptyline—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.32e-05	0.000523	CcSEcCtD
Nortriptyline—Rash—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.000519	CcSEcCtD
Nortriptyline—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.000518	CcSEcCtD
Nortriptyline—Headache—Lamivudine—acquired immunodeficiency syndrome	8.2e-05	0.000515	CcSEcCtD
Nortriptyline—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.15e-05	0.000512	CcSEcCtD
Nortriptyline—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.78e-05	0.000488	CcSEcCtD
Nortriptyline—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000487	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.41e-05	0.000484	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.000478	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.38e-05	0.000473	CbGpPWpGaD
Nortriptyline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.37e-05	0.000472	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.37e-05	0.000471	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.37e-05	0.000471	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.37e-05	0.000471	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.37e-05	0.00047	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000464	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000464	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.32e-05	0.000453	CbGpPWpGaD
Nortriptyline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.32e-05	0.000452	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.31e-05	0.000449	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.3e-05	0.000447	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000445	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000444	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.29e-05	0.000444	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.29e-05	0.000443	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.29e-05	0.000442	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.29e-05	0.000442	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.28e-05	0.00044	CbGpPWpGaD
Nortriptyline—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.28e-05	0.00044	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.26e-05	0.000434	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.25e-05	0.000431	CbGpPWpGaD
Nortriptyline—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.25e-05	0.00043	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.24e-05	0.000428	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000428	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000427	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000426	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000425	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.24e-05	0.000425	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000425	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000425	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000424	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000423	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.000421	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.000421	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.00042	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.22e-05	0.000419	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.000418	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.22e-05	0.000418	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000417	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.000413	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.000412	CbGpPWpGaD
Nortriptyline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.19e-05	0.00041	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.19e-05	0.00041	CbGpPWpGaD
Nortriptyline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.19e-05	0.000409	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.19e-05	0.000408	CbGpPWpGaD
Nortriptyline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.19e-05	0.000408	CbGpPWpGaD
Nortriptyline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.18e-05	0.000407	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.18e-05	0.000404	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.17e-05	0.000402	CbGpPWpGaD
Nortriptyline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.17e-05	0.000402	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.16e-05	0.0004	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.16e-05	0.0004	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.15e-05	0.000394	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000391	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.14e-05	0.000391	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.14e-05	0.00039	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000388	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.000388	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.000387	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000386	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000385	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000385	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000385	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000384	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000383	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.11e-05	0.000382	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000382	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.11e-05	0.000381	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.000381	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.11e-05	0.00038	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.00038	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000379	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.1e-05	0.000378	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.1e-05	0.000377	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.000375	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.000374	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.08e-05	0.000371	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.07e-05	0.000369	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.05e-05	0.00036	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.04e-05	0.000358	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.000355	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.03e-05	0.000354	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.03e-05	0.000353	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.03e-05	0.000353	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.03e-05	0.000353	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.03e-05	0.000352	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.02e-05	0.000351	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.000349	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000349	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.01e-05	0.000349	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.01e-05	0.000349	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.01e-05	0.000348	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000348	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000348	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.01e-05	0.000347	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.01e-05	0.000347	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.01e-05	0.000347	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000346	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.99e-06	0.000343	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.96e-06	0.000342	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.84e-06	0.000338	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.69e-06	0.000333	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	9.68e-06	0.000332	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.66e-06	0.000332	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.66e-06	0.000332	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.55e-06	0.000328	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.48e-06	0.000326	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.42e-06	0.000324	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.39e-06	0.000323	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.32e-06	0.00032	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.3e-06	0.00032	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.28e-06	0.000319	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.27e-06	0.000319	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.24e-06	0.000318	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.19e-06	0.000316	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.15e-06	0.000315	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.14e-06	0.000314	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.13e-06	0.000314	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.91e-06	0.000306	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.91e-06	0.000306	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.86e-06	0.000305	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.86e-06	0.000304	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.77e-06	0.000301	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.77e-06	0.000301	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.75e-06	0.000301	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.75e-06	0.000301	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.72e-06	0.0003	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.72e-06	0.0003	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.72e-06	0.0003	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.69e-06	0.000299	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.69e-06	0.000299	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.67e-06	0.000298	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.61e-06	0.000296	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.61e-06	0.000296	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.59e-06	0.000295	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.58e-06	0.000295	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.58e-06	0.000295	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.49e-06	0.000292	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.3e-06	0.000285	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.98e-06	0.000274	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.8e-06	0.000268	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.72e-06	0.000265	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.68e-06	0.000264	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.6e-06	0.000261	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.56e-06	0.00026	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.49e-06	0.000257	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.45e-06	0.000256	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.41e-06	0.000255	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	7.35e-06	0.000253	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.35e-06	0.000253	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.24e-06	0.000249	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.13e-06	0.000245	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.95e-06	0.000239	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.92e-06	0.000238	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.8e-06	0.000234	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.78e-06	0.000233	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.77e-06	0.000233	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.76e-06	0.000232	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.68e-06	0.000229	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.67e-06	0.000229	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.65e-06	0.000229	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.63e-06	0.000228	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.62e-06	0.000228	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.61e-06	0.000227	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.58e-06	0.000226	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.57e-06	0.000226	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.55e-06	0.000225	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.55e-06	0.000225	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.53e-06	0.000224	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.53e-06	0.000224	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.51e-06	0.000224	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.48e-06	0.000223	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.47e-06	0.000222	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.46e-06	0.000222	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.45e-06	0.000222	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.44e-06	0.000221	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.43e-06	0.000221	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.42e-06	0.00022	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.35e-06	0.000218	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.34e-06	0.000218	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.11e-06	0.00021	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.01e-06	0.000206	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.99e-06	0.000206	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.98e-06	0.000205	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.97e-06	0.000205	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.96e-06	0.000205	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.9e-06	0.000203	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.88e-06	0.000202	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.88e-06	0.000202	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.86e-06	0.000201	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.84e-06	0.000201	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.83e-06	0.0002	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.77e-06	0.000198	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.77e-06	0.000198	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.75e-06	0.000198	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	5.72e-06	0.000197	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.43e-06	0.000187	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.4e-06	0.000186	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.12e-06	0.000176	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.09e-06	0.000175	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	5.08e-06	0.000174	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.9e-06	0.000168	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.88e-06	0.000168	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.61e-06	0.000158	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.59e-06	0.000158	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	4.28e-06	0.000147	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	4.27e-06	0.000147	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.02e-06	0.000138	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4e-06	0.000137	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4e-06	0.000137	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.98e-06	0.000137	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.83e-06	0.000131	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.81e-06	0.000131	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.53e-06	0.000121	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.51e-06	0.000121	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.47e-06	0.000119	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.46e-06	0.000119	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.45e-06	0.000119	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.45e-06	0.000119	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.45e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.44e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.44e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.42e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.41e-06	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.4e-06	0.000117	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.39e-06	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.38e-06	0.000116	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	3.3e-06	0.000113	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.19e-06	0.00011	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.04e-06	0.000104	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.01e-06	0.000103	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.01e-06	0.000103	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.88e-06	9.9e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.71e-06	9.31e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	2.57e-06	8.83e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.36e-06	8.11e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.35e-06	8.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.25e-06	7.73e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.07e-06	7.12e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.04e-06	7.01e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.04e-06	7e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.03e-06	6.97e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.02e-06	6.95e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2e-06	6.88e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2e-06	6.86e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.98e-06	6.82e-05	CbGpPWpGaD
